A O Smith Shares Draw Mixed Analyst Ratings As Market Assesses Growth Prospects Pinterest Analyst Assessment Suggests Mixed Market Outlook Strategy Inc Pauses Bitcoin Accumulation Prioritizes 15B Bond Repurchase Plus500 Reports 11 Revenue Growth in Latest Quarter Reaffirms FullYear Outlook Consumer Credit Growth Accelerates in December Amid Holiday Spending Surge Morgan Stanley Highlights Potential Turnaround for Franklin Resources BEN Newmont Q1 2026 Earnings Strong EPS Beat Driven by Robust Gold Production and Cost Discipline DJCO Q4 2025 Earnings Strong EPS Beat Amid Sparse Disclosure East West Bancorp Inc Q1 2026 Earnings Modest EPS Beat Amid Steady Operations TCBX Q1 2026 Earnings EPS Beats Estimates by 363 as Net Interest Income Drives Performance PHVS Q1 2026 Earnings NarrowerThanExpected Loss as Biotech Advances HAE Pipeline UAMY Q1 2026 Earnings EPS Falls Far Short of Estimates as Revenue Remains Unreported iQSTEL IQST Sheds Over 4 as Stock Tests Critical Support Zone Oak Valley Bancorp OVLY Slips 108 as Stock Tests Support Near 3125 Title Civeo Corporation CVEO Edges Higher Testing Key Resistance Near 372 MacroGenics MGNX Surges 684 Biotech Stock Approaches Key Resistance at 476 Inspire Medical Systems Shares Decline 422 as Stock Tests Key Support Levels Gilead Sciences Acquires Tubulis in 315 Billion Deal to Strengthen Oncology Pipeline Oppenheimer Suggests Golub Capitals Fair Value May Align Closely with Book Value US Prioritizes AI Integration in China and Asia Following TrumpXi Talks Dropbox Founder Drew Houston Transitions to Executive Chairman After Nearly Two Decades Google Employee Charged with Insider Trading for 12 Million in Bets Using Internal Data US Consumer Prices Rise 38 Annually in April Exceeding Expectations and Marking Highest Since May 2023 Tracker Mortgages Regain Popularity Amid Uncertain Interest Rate Outlook Token Cat Limited TC Q3 2021 Earnings WiderThanExpected Loss Highlights Operational Challenges SAB Biotherapeutics SABS Slides 381 as Biotech Sector Faces Headwinds Key Support Tested Crinetics Pharmaceuticals CRNX Slips 152 as Biotech Sentiment Remains Cautious Brookfield Property Partners LP Preferred Stock BPYPN Holds Steady Near 14 Up 022 EDU Shows Modest Uptick Amid Sector Consolidation Support and Resistance Levels in Focus Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29 UTStarcom Holdings UTSI Tests Support at 248 After Marginal Decline Above Food Ingredients Inc ABVE Surges 9 as Buyers Test Key Resistance Silicon Laboratories Inc SLAB Notches Modest Gain Amid Semiconductor Sector Tailwinds